AK-106, formerly known as AK106-001616, is a selective inhibitor of cytosolic phospholipase A2 (cPLA2) inhibitor. AK-106 has been shown to have analgesic activites similar to non-steroidal anti-inflammatory drugs (NSAIDs). References: Shimizu H, Ito A, Sakurada K, Nakamura J, Tanaka K, Komatsu M, Takeda M, Saito K, Endo Y, Kozaki T, Shoda M, Kuriyama H. AK106-001616, a potent and selective inhibitor of cytosolic phospholipase A2: in vivo efficacy for inflammation, neuropathic pain, and pulmonary fibrosis. J Pharmacol Exp Ther. 2019 Apr 10. pii: jpet.118.255034. doi: 10.1124/jpet.118.255034. [Epub ahead of print] PubMed PMID: 30971478.

纯度：≥98%

CAS：590416-75-4